WO1997009449A1 - Identification of bases in nucleic acid sequences - Google Patents
Identification of bases in nucleic acid sequences Download PDFInfo
- Publication number
- WO1997009449A1 WO1997009449A1 PCT/GB1996/002136 GB9602136W WO9709449A1 WO 1997009449 A1 WO1997009449 A1 WO 1997009449A1 GB 9602136 W GB9602136 W GB 9602136W WO 9709449 A1 WO9709449 A1 WO 9709449A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- primer
- nucleic acid
- sequence
- base
- extension
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
Definitions
- the present invention relates to the identification of bases in nucleic acid sequences.
- the invention relates more particularly to a method of determining whether or not a particular base is present at a specified position in a nucleic acid sequence.
- a particular application of the invention is in determining whether or not there is a mutation in a gene.
- the mutation may. for example, be a deletion which results in the formation of truncated mRNA which in turn results in the formation of a protein having incorrect amino acid residues such that the protein has an incorrect function or no function at all.
- the mutation may be an insert either wholesale (e.g. the introduction of a viral sequence) or on a small scale by evolution or the introduction of single or multiple nucleotides as a result of DNA polymerase misreading.
- a further example of a mutation is a point mutation which is the result of a base change at a particular site within the genetic code.
- Examples of conditions caused by mutations in genes include Gaucher, Cystic Fibrosis. and ⁇ and ⁇ Thalasseamias. Many of the mutations which cause such diseases are known and it is therefore possible to determine whether a patient is afflicted by, or susceptible to. a particular condition by assaying DNA from the patient to determine whether or not the mutation which causes that condition is present in the DNA. This involves determining whether or not a specific base is present at a particular position in a certain gene sequence.
- WO-A-9009455 Genetic assay technique
- a primer is hybridised to the gene sequence on the 3 side of the base to be investigated, the primer being one which inco ⁇ orates a detection element or a separation element.
- An extension reaction is then effected such that, if the specific base is present, the primer is extended to (and only to) that specific base in the sequence being investigated.
- the base in the extended primer which is complementary to the specific base in the sequence under investigation incorporates a detection element and/or a separation element such that the extended primer as a whole incorporates both a detection element and a separation element.
- the presence of the separation element in the extended primer then allows the primer to be denatured from the original sequence and to be exposed to a solid suppo ⁇ provided with a moiety having affinity for the separation element.
- the support is then treated to determine the presence of (or otherwise) of labelled primer immobilised thereon. If (but only if) the label is detected this is confirmation that the specific base was present at the particular position in the sequence under investigation.
- a method of determining whether or not a particular base is present at a specified position in a nucleic acid sequence comprising the steps of
- sample sequence a single stranded sample of the sequence to be investigated (the "sample sequence") in immobilised form on a solid support-
- the method of the invention is used for determining whether or not a particular base is present at a specified position in the sample nucleic acid. If that base is present at that position then a label is inco ⁇ orated on the primer extension product produced as a result of step (c). The presence of that label, as detected by step (e), confirms that the particular base was present at the position under investigation.
- the detection may be effected with the primer hybridised to the sample sequence or after denaturation therefrom. In either case, interference from unreacted labelled moiety is avoided by the washing procedure of step (d) which ensures that all such unreacted labelled moiety (and other reagents) are removed prior to the detection step.
- the method ofthe invention avoids the need for inco ⁇ oration of a separation element into the extended primer and a subsequent affinity step for immobilising extended primer on a support. The invention therefore readily lends itself to automation.
- the labelled moiety may, for example, be a dideoxynucleotide inco ⁇ orating the complementary base to that at the specified position in the sample sequence.
- extension of the primer will occur only if the particular base is present at the specified position of the sample sequence and will not continue any further since the dideoxynucleotide terminates the extension reaction.
- the presence of the labelled species in the primer obviously then confirms the presence ofthe particular base at the specified position.
- a dideoxynucleotide or other species which terminate the extension reaction
- the label can be Biotin, allowing the introduction of secondary labels, a fluorophore, enzyme, chemiluminescent tag or similar groups.
- sample nucleic acid may be provided in a number of ways. It is however highly preferred that the sample nucleic acid is covalently linked to the solid support. This may be achieved using the following procedure.
- the procedure will start with a sample of nucleic acid ("the original nucleic acid") obtained from a patient.
- the solid supports will initially be provided with oligonucleotides covalently linked by their 5 ends to the supports. These oligonucleotides will be complementary to a sequence in a strand of the original nucleic acid. By providing that strand in single stranded form, it may be hybridised to the oligonucleotides on the support thereby trapping that strand of the original nucleic acid. After washing to remove non-hybridised material. an extension reaction may be effected so as to extend the oligonucleotides using the trapped original nucleic acid as a template.
- the original nucleic acid may then be denatured and washed off the supports leaving its immobilised, single stranded copy as the sample nucleic acid on which the method of the invention is effected.
- the sample nucleic acid is complementary to the original nucleic acid. Therefore in order to determine whether or not there is a particular base at a specified position in the original nucleic acid, it is necessary to determine whether the complement of that base is present at the corresponding position in the sample nucleic acid.
- the amount of the original nucleic acid is relatively low. it is possibly to produce increased amounts of sample nucleic acid for use in the method of the invention using the procedures described in WO-A-93/13220 (Tepnel) and WO-A- 95/33073 (Tepnel) thereby producing larger numbers of strands of the sample nucleic acid covalently linked to the support.
- the solid support initially to be provided with oligonucleotides covalently linked by their 3 ends to the solid support.
- the original nucleic acid may once again be trapped on the oligonucleotides but, in this case, is itself used as the sample nucleic acid.
- the solid support preferably comprises particles having a size of 50 to 200 (more preferably 100 to 200) microns. Particularly preferred examples of particles, and methods by which nucleic acids may be covalently linked thereto, are disclosed in WO-A-93/13220.
- the particles are provided in a flow-through column into and from which reagents may be readily introduced and exhausted, e.g. as disclosed in WO-A- 93/13220.
- the method may be used for determining whether or not several different nucleotides are present at specified positions in the sample nucleic acid.
- Fig.1 illustrates preparation of a sample nucleic acid for analysis in accordance with the method ofthe invention
- Fig. 2 illustrates a first embodiment of method in accordance with the invention
- Fig. 3 illustrates a second embodiment in accordance with the invention.
- Figs. 4 to 7 illustrate procedures and results ofthe Examples.
- Fig.l illustrates the production of a solid support system inco ⁇ orating single stranded nucleic acid (the sample nucleic acid) for use in the method of the invention as described more fully below with reference to Figs. 2 and 3.
- step (b) single stranded nucleic acid 3 which is to be investigated to determine whether a particular mutation is present therein, the nucleic acid 3 having a region complementary to the immobilised oligonucleotides 2.
- the strands 3 are hybridised to oligonucleotide 2 using standard reagents and procedures. After washing to remove reagents and non-hybridised materials, the oligonucleotides 2 are extended using a polymerase enzyme and a mixture of dATP, dTTP, dCTP, and dGTP. The extended strands (which are complementary to strands 3) are referenced as 4.
- the original strands 3 are then denatured and washed off the support leaving the immobilised strands 4 as sample nucleic acid strands.
- a primer 5 is hybridised to the strand 4 so that the 3 end of the primer is immediately adjacent to that position (marked with a "+") in the strand 4 at which the base is to be determined.
- the primer 5 is homologous for the region one base downstream (i.e. on the 3 side of ) the possible mutation point
- the supports are then washed to remove reagents and non-hybridised material.
- dATP dATP
- polymerase enzyme e.g. an enzyme label.
- An extension reaction is the effected followed by washing of the solid support system (leaving the primer 5 hybridised to the strand 4).
- a detection procedure is then effected to determine whether labelled dTTP has been inco ⁇ orated in the primer 5. For the procedure illustrated in Fig. 2 the result would be positive.
- labelled dGTP together with polymerase enzyme are added to the support system and an extension reaction again effected using the immobilised primer. After washing of the system, the detection procedure is repeated to confirm that the labelled dGTP has become inco ⁇ orated on the primer and therefore that the original strand 3 was a mutant.
- the procedure described with reference to Fig. 2 makes it possible to assay for single point mutations in a controlled manner. There is no requirement for gel electrophoresis, blotting or other labour intensive and delicate processes.
- the copy 4 is, in addition, stable and can be repeatedly assayed.
- Fig.3 A development of the procedure is shown in Fig.3 and is used for simultaneously determining the presence (or otherwise) of more than one mutation.
- up to four primers are simultaneously hybridised to the strand 4. each for determining whether particular mutations are present at specified positions.
- the series of primers may be complementary to regions adjacent to a cluster of point or frame shift mutations. They could also be complementary to insert mutation or mutations.
- primers 14-17 are hybridised to each sequence of interest, each primer being homologous for the region one base downstream (i.e. on the 3 side of) the possible point mutations.
- the supports are then washed to remove non-hybridised primers and other reagents.
- Labelled dATP i.e. *dATP
- the supports are then washed and the procedure repeated sequentially with *dCTP, *dGTP and & *dTTP.
- *dATP labelled dATP
- a detection procedure is effected on the supports to determine which nucleotides have been inco ⁇ orated. Since the nucleotides were differently labelled, it is possible to determine which nucleotides. if any, have been inco ⁇ orated.
- the different labels may for example be fluorophores which adsorb at different wavelengths.
- Fig. 3 represents an idealised case in that the four mutations each correspond to a different nucleotide. If two or more of the mutations were the same nucleotide then it would be possible to determine from the strength of the detection signal obtained for any one nucleotide how many mutations corresponding to that nucleotide were present in the sequence.
- the experiment describes the addition of a biotinylated nucleotide to a probe (DOL024) hybridised to an extended copy of a captured 257bp PCR fragment, 2570.
- Capture and extension was performed on solid support carrying the 24mer oligonucleotide DOL006.
- the fragment was captured on this support and an extension copy of this was made by initiating extension of the support-bound oligonucleotide using AmpliTaq polymerase (Perkin Elmer) and a mixture of the four deoxyribonucleotides.
- the extension product was used to capture the oligonucleotide DOL024B (see below).
- the experiment was designed such that the probe was located at the distal (3') end of the solid phase extension product, allowing the hybrid, shown in Fig. 4, to be formed.
- the sequence ofthe DOL024 primer was such that the nucleotide dG should be inco ⁇ orated as the first 5' base.
- Biotinylated dideoxyGTP was used to test for successful inco ⁇ oration, while biotinylated deoxyUTP was used to check the specificity of inco ⁇ oration.
- the 2570 fragment (500 fmol) was introduced to the support (2mg), which was located in flow-through columns. The mixture was denatured (95°C, 5 minutes) prior to capture (37°C. 10 minutes). Following washing to remove uninco ⁇ orated fragment, extension was initiated by the introduction of an extension mix containing AmpliTaq DNA polymerase (2.5 U ⁇ L " ) and a mixture of the four deoxyribonucleotides (0.2 pmol ⁇ L " each) in 1 x PCR buffer (supplied with the polymerase enzyme).
- Extension proceeded during an incubation stage (72°C, 5 minutes), after which the captured fragment was removed by "melting” and washing (3 x 95°C, 5 minutes followed by 80 ⁇ L wash) to leave the extended copy attached to the support (see Fig. 4).
- the extension copy was probed by aspirating 500 fmol of DOLO24 onto the support and capturing (37°C, 5 minutes). Following washing to remove unbound material the nucleotide under investigation was added (25 pmol) together with AmpliTaq DNA polymerase (2.5 U ⁇ L " ) in 1 x PCR buffer. Inco ⁇ oration ofthe nucleotide was achieved during incubation at 72°C for 5 minutes.
- inco ⁇ orated material was detected by binding of a Streptavidin Alkaline Phosphatase conjugate followed by spectrophotometric detection using the AMPAK assay.
- Controls involved the use of biotinylated capture probe (DOL024B) at the same levels as DOLO240, above, without nucleotide addition, in order to determine the level of capture of the secondary probe. The results are shown in Fig. 5.
- This example demonstrates the feasibility of capturing two primers on single stranded nucleic acid.
- the 24mer oligonucleotide DOL006 (see below) was covalently immobilised by its 5' end on particulate solid supports.
- the 257bp PCR fragment, 2570 was captured on this support and an extension copy of this was made by initiating extension of the support-bound oligonucleotide using AmpliTaq polymerase (Perkin Elmer) and a mixture ofthe four deoxyribonucleotides.
- the extension product was multiply probed using the biotinylated oligonucleotides DOL024B and
- the oligonucleotides are designed such that the two detection probes are located at either end of the solid phase extension product, allowing the multiply primed hybrid shown in Fig. 6 to be formed.
- the 2570 fragment (500fmol) was introduced to the support (2mg), which was located in flow-through columns.
- the mixture was denatured (95°C, 5 minutes) prior to capture (37°C, 10 minutes).
- extension was initiated by the introduction of an extension mix containing AmpliTaq DNA polymerase (2.5 U ⁇ L " ) and a mixture of the four deoxyribonucleotides (0.2 pmol ⁇ L " each) in 1 x PCR buffer (supplied with the polymerase enzyme).
- Extension proceeded during an incubation stage (72°C, 5 minutes), after which the captured fragment was removed by "melting” and washing (3 x 95°C, 5 minutes followed by 80 ⁇ L wash) to leave the extended copy attached to the support.
- the extension copy was probed by aspirating 500 fmol of detection probe onto the support and capturing (37°C, 5 minutes). Following washing to remove unbound material secondary probes, where necessary, were captured in exactly the same way.
- the columns were then thoroughly washed and the bound probes detected by binding of a Streptavidin Alkaline Phosphatase conjugate followed by spectrophotomeric detection using an AMPAK assay. The results are shown in Fig.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL12351396A IL123513A0 (en) | 1995-09-02 | 1996-09-02 | Identification of bases in nucleic acid sequences |
EP96928620A EP0850317A1 (en) | 1995-09-02 | 1996-09-02 | Identification of bases in nucleic acid sequences |
AU68339/96A AU6833996A (en) | 1995-09-02 | 1996-09-02 | Identification of bases in nucleic acid sequences |
JP9510940A JPH11511981A (en) | 1995-09-02 | 1996-09-02 | Identification of bases in nucleic acid sequences |
NO980837A NO980837L (en) | 1995-09-02 | 1998-02-27 | Identification of bases in nucleic acid sequences |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9517914.9A GB9517914D0 (en) | 1995-09-02 | 1995-09-02 | Identification of bases in nucleic acid sequences |
GB9517914.9 | 1995-09-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997009449A1 true WO1997009449A1 (en) | 1997-03-13 |
Family
ID=10780089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1996/002136 WO1997009449A1 (en) | 1995-09-02 | 1996-09-02 | Identification of bases in nucleic acid sequences |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0850317A1 (en) |
JP (1) | JPH11511981A (en) |
AU (1) | AU6833996A (en) |
CA (1) | CA2230893A1 (en) |
GB (1) | GB9517914D0 (en) |
IL (1) | IL123513A0 (en) |
NO (1) | NO980837L (en) |
WO (1) | WO1997009449A1 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999055912A1 (en) * | 1998-04-27 | 1999-11-04 | Exact Laboratories, Inc. | Primer extension methods for detecting nucleic acids |
US6146828A (en) * | 1996-08-14 | 2000-11-14 | Exact Laboratories, Inc. | Methods for detecting differences in RNA expression levels and uses therefor |
US6280947B1 (en) | 1999-08-11 | 2001-08-28 | Exact Sciences Corporation | Methods for detecting nucleotide insertion or deletion using primer extension |
US6326489B1 (en) | 1997-08-05 | 2001-12-04 | Howard Hughes Medical Institute | Surface-bound, bimolecular, double-stranded DNA arrays |
US6432360B1 (en) | 1997-10-10 | 2002-08-13 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
US6485944B1 (en) | 1997-10-10 | 2002-11-26 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
US6849403B1 (en) | 1999-09-08 | 2005-02-01 | Exact Sciences Corporation | Apparatus and method for drug screening |
US6919174B1 (en) | 1999-12-07 | 2005-07-19 | Exact Sciences Corporation | Methods for disease detection |
US6964846B1 (en) | 1999-04-09 | 2005-11-15 | Exact Sciences Corporation | Methods for detecting nucleic acids indicative of cancer |
US7368233B2 (en) | 1999-12-07 | 2008-05-06 | Exact Sciences Corporation | Methods of screening for lung neoplasm based on stool samples containing a nucleic acid marker indicative of a neoplasm |
US7785790B1 (en) | 1997-10-10 | 2010-08-31 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
US9109256B2 (en) | 2004-10-27 | 2015-08-18 | Esoterix Genetic Laboratories, Llc | Method for monitoring disease progression or recurrence |
US9777314B2 (en) | 2005-04-21 | 2017-10-03 | Esoterix Genetic Laboratories, Llc | Analysis of heterogeneous nucleic acid samples |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990009455A1 (en) * | 1989-02-13 | 1990-08-23 | Geneco Pty Ltd | Detection of a nucleic acid sequence or a change therein |
WO1991013075A2 (en) * | 1990-02-16 | 1991-09-05 | Orion-Yhtymä Oy | Method and reagent for determining specific nucleotide variations |
WO1992016657A1 (en) * | 1991-03-13 | 1992-10-01 | E.I. Du Pont De Nemours And Company | Method of identifying a nucleotide present at a defined position in a nucleic acid |
WO1993013220A1 (en) * | 1991-12-24 | 1993-07-08 | Tepnel Medical Limited | Manipulating nucleic acid sequences |
WO1993023562A1 (en) * | 1992-05-12 | 1993-11-25 | Cemu Bioteknik Ab | Chemical method for the analysis of dna sequences |
GB2283815A (en) * | 1993-11-04 | 1995-05-17 | Tepnel Medical Ltd | Immobilising nucleic acid to a solid support |
-
1995
- 1995-09-02 GB GBGB9517914.9A patent/GB9517914D0/en active Pending
-
1996
- 1996-09-02 IL IL12351396A patent/IL123513A0/en unknown
- 1996-09-02 JP JP9510940A patent/JPH11511981A/en not_active Ceased
- 1996-09-02 EP EP96928620A patent/EP0850317A1/en not_active Withdrawn
- 1996-09-02 AU AU68339/96A patent/AU6833996A/en not_active Abandoned
- 1996-09-02 WO PCT/GB1996/002136 patent/WO1997009449A1/en not_active Application Discontinuation
- 1996-09-02 CA CA002230893A patent/CA2230893A1/en not_active Abandoned
-
1998
- 1998-02-27 NO NO980837A patent/NO980837L/en unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990009455A1 (en) * | 1989-02-13 | 1990-08-23 | Geneco Pty Ltd | Detection of a nucleic acid sequence or a change therein |
WO1991013075A2 (en) * | 1990-02-16 | 1991-09-05 | Orion-Yhtymä Oy | Method and reagent for determining specific nucleotide variations |
WO1992016657A1 (en) * | 1991-03-13 | 1992-10-01 | E.I. Du Pont De Nemours And Company | Method of identifying a nucleotide present at a defined position in a nucleic acid |
WO1993013220A1 (en) * | 1991-12-24 | 1993-07-08 | Tepnel Medical Limited | Manipulating nucleic acid sequences |
WO1993023562A1 (en) * | 1992-05-12 | 1993-11-25 | Cemu Bioteknik Ab | Chemical method for the analysis of dna sequences |
GB2283815A (en) * | 1993-11-04 | 1995-05-17 | Tepnel Medical Ltd | Immobilising nucleic acid to a solid support |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6146828A (en) * | 1996-08-14 | 2000-11-14 | Exact Laboratories, Inc. | Methods for detecting differences in RNA expression levels and uses therefor |
US6566101B1 (en) | 1997-06-16 | 2003-05-20 | Anthony P. Shuber | Primer extension methods for detecting nucleic acids |
US6326489B1 (en) | 1997-08-05 | 2001-12-04 | Howard Hughes Medical Institute | Surface-bound, bimolecular, double-stranded DNA arrays |
US6432360B1 (en) | 1997-10-10 | 2002-08-13 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
US6485944B1 (en) | 1997-10-10 | 2002-11-26 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
US7785790B1 (en) | 1997-10-10 | 2010-08-31 | President And Fellows Of Harvard College | Replica amplification of nucleic acid arrays |
WO1999055912A1 (en) * | 1998-04-27 | 1999-11-04 | Exact Laboratories, Inc. | Primer extension methods for detecting nucleic acids |
US6964846B1 (en) | 1999-04-09 | 2005-11-15 | Exact Sciences Corporation | Methods for detecting nucleic acids indicative of cancer |
US6280947B1 (en) | 1999-08-11 | 2001-08-28 | Exact Sciences Corporation | Methods for detecting nucleotide insertion or deletion using primer extension |
US6849403B1 (en) | 1999-09-08 | 2005-02-01 | Exact Sciences Corporation | Apparatus and method for drug screening |
US6919174B1 (en) | 1999-12-07 | 2005-07-19 | Exact Sciences Corporation | Methods for disease detection |
US7368233B2 (en) | 1999-12-07 | 2008-05-06 | Exact Sciences Corporation | Methods of screening for lung neoplasm based on stool samples containing a nucleic acid marker indicative of a neoplasm |
US9109256B2 (en) | 2004-10-27 | 2015-08-18 | Esoterix Genetic Laboratories, Llc | Method for monitoring disease progression or recurrence |
US9777314B2 (en) | 2005-04-21 | 2017-10-03 | Esoterix Genetic Laboratories, Llc | Analysis of heterogeneous nucleic acid samples |
Also Published As
Publication number | Publication date |
---|---|
NO980837D0 (en) | 1998-02-27 |
CA2230893A1 (en) | 1997-03-13 |
GB9517914D0 (en) | 1995-11-01 |
EP0850317A1 (en) | 1998-07-01 |
AU6833996A (en) | 1997-03-27 |
JPH11511981A (en) | 1999-10-19 |
NO980837L (en) | 1998-04-30 |
IL123513A0 (en) | 1998-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9593328B2 (en) | Method of nucleic acid amplification | |
KR20020008195A (en) | Microarray-based analysis of polynucleotide sequence variations | |
JP2007525151A (en) | Method for preparing single-stranded DNA library | |
JP2000500024A (en) | Nucleotide sequencing | |
WO1993004199A2 (en) | Methods of detecting or quantitating nucleic acids and of producing labelled immobilised nucleic acids | |
WO2004050915A1 (en) | Determination of methylation of nucleic acid sequences | |
WO1997009449A1 (en) | Identification of bases in nucleic acid sequences | |
US20020048760A1 (en) | Use of mismatch cleavage to detect complementary probes | |
WO1999034214A1 (en) | Solid-phase tips and uses relating thereto | |
US20020164634A1 (en) | Methods for reducing complexity of nucleic acid samples | |
EP1951894A1 (en) | Microarrays for genotyping and methods of use | |
US20050003366A1 (en) | Method for reusing standard blots and microarrays utilizing DNA dendrimer technology | |
JP2004024247A (en) | Probe for detecting gene mutation and method for detecting gene mutation | |
JP2006508677A (en) | Oligonucleotide-induced analysis of gene expression | |
JP5378724B2 (en) | Expression mRNA identification method | |
AU2002357968A1 (en) | Method and integrated device for the detection of cytosine methylations | |
WO2003070977A2 (en) | Method for detecting single nucleotide polymorphisms | |
EP1322777A1 (en) | Methods for reducing complexity of nucleic acid samples | |
JP2004500062A (en) | Methods for selectively isolating nucleic acids | |
GB2284051A (en) | Quantitative determination of nucleic acids using enzyme labels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2230893 Country of ref document: CA Ref document number: 2230893 Country of ref document: CA Kind code of ref document: A Ref document number: 1997 510940 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996928620 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 96197830.9 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 1996928620 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996928620 Country of ref document: EP |